Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients

INDIANAPOLIS, Sept. 14, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today initial data emerging from the Adaptive COVID-19 Treatment Trial (ACTT-2) sponsored by the National Institute of...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials